CARES: Chicago Association for Research and Education in Science

Click here to donate


Home
About Cares
Donations
Policies
Forms
FAQ's
Links

Click here to donate








BIOGRAPHICAL SKETCH

JANICE L. GILDEN, M.D.

Staff Physician, Endocrinology Section
Professor of Medicine

Medical Service (111E)
VA Medical Center
3001 Green Bay Road
North Chicago, IL 60064
(847) 578-6935 - Fax
janice.gilden@med.va.gov

Finch University of Health Sciences/
The Chicago Medical School
Department of Medicine/Endocrinology
3333 Green Bay Road (#111E)
North Chicago, IL 60064
(847) 688-1900, x84574
(847) 578-6935 - Fax

Clinical Coordinator:
Ellen Legon Hoverson, RN, BSN
(847) 688-1900 x84710
(847) 799-3707 - Pager

Academic & Professional Background

  • BA (Biological Sciences) 1974 - Northwestern University, Evanston, Illinois
  • MS (Cellular Biology) 1975 - Northwestern University, Evanston, Illinois
  • MD 1978 - State University of New York, Downstate Medical Center, Brooklyn, New York
  • Intern (Internal Medicine) 1978-1979 - Luthern General Hospital, Park Ridge, Illinois
  • Resident (Internal Medicine) 1979-1981 - Luthern General Hospital, Park Ridge, Illinois
  • Fellow (Endocrinology) 1981-1984 - The University of Chicago
  • Fellow (Clinical Pharmacology) 1983-1984 - The University of Chicago

Current Research Interests

  • Diabetes Mellitus Control & Complications
  • Diabetic Neuropathy/Orthostatic Hypotension
  • Diabetes Mellitus - Psychosocial Factors & Health Care Outcomes
  • Aging and Endocrine System
  • Women's Health Care

Selected Publications

Gilden JL. Major cardiovascular events in hypertensive patients randomized to Doxazocin vs Chlorthalidone-ALHAT. JAMA 283:1967-1973, 2000.

Gilden JL. Nutrition and the older diabetic. Clin Geriatric Med 12, No 2: 370-390, 1999.

Gilden JL. Orthostatic hypotension in individuals with diabetes. Diabetes Spectrum 11:237-241, 1998.

Low PA, Gilden JL, Freeman R, Wilson J, McElligott MA. Randomized double-blind multicenter study comparing midodrine with placebo in neurogenic orthostatic hypotension. JAMA, 1997.

Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, Rubin M, Foud-Tarazi FM. Neurogenic orthostatic hypotension: A double-blind placebo-controlled study with midodrine. Am J Med 95:38-48, 1993.

Gilden JL. Midodrine in orthostatic hypotension: A new treatment. International Angiology 12(2):125-131, 1993.

Gilden JL. Etiology and treatment of orthostatic hypotension. Consultant 33(5):117-120, 1993.

Gilden JL, Hendryx M, Clar SA, Casia C, Singh SP. Support groups improve health care in older diabetic patients. J Am Geriatrics Soc 40:147-150, 1992.

Gilden JL, Singh SP, Fulambarker A, Vega D, Pollock J, Douglas FL. Role of endogenous opioids on glucose homeostasis during exercise in normals and patients with insulin-dependent diabetes mellitus. Adv Life Sci (Clinical Endocrinology), 1992.

Gilden JL. Screening recommendations for diabetes mellitus. Consultant 31:51-56, 1991.

Gilden JL. The aging endocrine system. Internal Medicine News World Report 6(19):41-48, 1991.

Gilden JL, Casia C, Hendryx M, Singh SP. Effects of self-monitoring of blood glucose on the quality of life in elderly diabetic patients. J Am Geriatric Soc 38:511-515, 1990.

Gilden JL. Diabetes education programs and sexual dysfunction. Human Sexuality: Lett, 1990.

Projects Completed or Active (Selected)

  • Randomized Trial of Voglibose in Type II Diabetes Mellitus Patients
  • A Placebo-Controlled Safety and Efficacy Study of Pimagedine in Patients with Type II Diabetes Mellitus and Overt Nephropathy
  • Study of Midodrine in Patients with Neurogenic Orthostatic Hypotension
  • Allhat (Antihypertensive Lipid Lowering Trial)
  • Randomized Trial of Uoglibose in Type II Diabetes Mellitis Patients
  • Comparison of Lispro to NPH in Patients with Uncontrolled Type 2 Diabetes on Oral Antihyperglycemic Agents
  • Comparison of Low Mix 75:25 to NPH in Patients with Uncontrolled Type 2 Diabetes on Oral Antihyperglycemic Agents
  • Topiramate in Patients with Diabetic Polyneuropathy
  • Evaluation of RWJ 0486 in Patients with Uncontrolled Type 2 Diabetes Mellitus

Research Funding Sources

  • American Diabetes Association
  • Boehringer Mannheim Pharmaceuticals
  • Ciba Geigy
  • Fraternal Order of Eagles
  • Robert Wood Johnson Pharmaceuticals
  • Eli Lilly Pharmaceuticals
  • Marion Merrill Dow
  • National Institutes of Health
  • Pfizer Pharmaceuticals
  • Retirement Research Foundation
  • Roberts Pharmaceuticals
  • Shire-Roberts Pharmaceuticals
  • VA Health Services Research & Development

Research Methods Employed

  • Neurologic Testing in Diabetes

Professional Accomplishments

  • 1983-present - Medical Commission, United States Fencing Association
  • 1984-present - Medical Director, United States Fencing Association National Championships and Olympic Trials
  • 1990 - Reviewer, Diabetes Care and Journal of the American Geriatrics Society
  • 1994-present - Reviewer, Research in Clinical Autonomic Nervous System
  • 1997 - Member, Editorial Board, The Medical Letter
  • 2000-present - Board of Directors, American Autonomic Society

Honors

  • 1983, 1985, 1986 - Young Investigator's Award, American Diabetes Association, Northern Illinois Affiliate
  • 1993 - Named Top Diabetologist and Top Endocrinologist in Chicago, Chicago Magazine
  • 1998 - Certificate of Appreciation for Contribution to Medical Center at North Chicago VA
  • 2000 - American College of Physicians-American Society of Internal Medicine Teaching Award









©2005-2010 Chicago Association for Research and Education in Science. All Rights Reserved. Web Design and Development by Americaneagle.com